ADC Therapeutics Receives Orphan Drug Designation in Europe for ZYNLONTA®
Go back to ADC Therapeutics Receives Orphan Drug Designation in Europe for ZYNLONTA®| ADC TELECOMM (NYSE: ADCT) | Delayed: 1.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.32 | 52 Week High | $12.76 | |||
| Open | $1.32 | 52 Week Low | $5.18 | |||
| Day High | $1.37 | P/E | 1.69 | |||
| Day Low | $1.30 | EPS | $0.78 | |||
| Volume | 2,774,744 | |||||
